AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaInformation ScienceNamed GroupsHealth CareGeographicals
Hematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningTransplantation, AutologousHematologic NeoplasmsPeripheral Blood Stem Cell TransplantationTransplantation ChimeraBone Marrow TransplantationStem CellsGraft vs Leukemia EffectRecurrenceTreatment OutcomeMyeloablative AgonistsTissue DonorsBusulfanRemission InductionGraft vs Tumor EffectVidarabineGraft SurvivalHistocompatibility TestingLeukemia, Myeloid, AcuteLeukemiaImmunosuppressive AgentsLymphocyte TransfusionRetrospective StudiesMultiple MyelomaCombined Modality TherapyLeukemia, Myelogenous, Chronic, BCR-ABL PositiveWhole-Body IrradiationSiblingsCytomegalovirus InfectionsCord Blood Stem Cell TransplantationSalvage TherapyMinor Histocompatibility AntigensHematopoietic Stem CellsLymphocyte DepletionSurvival AnalysisPrecursor Cell Lymphoblastic Leukemia-LymphomaDisease-Free SurvivalMyelodysplastic SyndromesNeoplasm, ResidualHistocompatibilitySurvival RateAntilymphocyte SerumLiver TransplantationVirus ActivationMelphalanTime FactorsChimerismT-LymphocytesHepatic Veno-Occlusive DiseaseCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsCytomegalovirusHematopoietic Stem Cell MobilizationAcute DiseaseMesenchymal Stem Cell TransplantationFollow-Up StudiesAnemia, AplasticHLA AntigensPrognosisPrimary MyelofibrosisCell TransplantationHematologic DiseasesTransplantation ImmunologyKidney TransplantationLeukemia, Myeloid, Accelerated PhaseImmunosuppressionAntigens, CD34CytarabineEmbryonic Stem CellsLeukemia, MyeloidAntibodies, NeoplasmBenzamidesAntineoplastic AgentsRoseolovirus InfectionsLymphoproliferative DisordersFusion Proteins, bcr-ablImmunocompromised HostGraft RejectionHodgkin DiseaseAdult Stem CellsPyrimidinesNuclear FamilyTransplantation, IsogeneicReceptors, Purinergic P2X5Lymphoma, Non-HodgkinCyclosporineGranulocyte Colony-Stimulating FactorLeukocyte TransfusionImmunotherapy, AdoptiveGanciclovirInfectionPiperazinesFatal OutcomeFlow CytometryHeart TransplantationProspective Studies

No FAQ available that match "reduced intensity allo sct relapse after allogeneic allogeneic stem cell transplantation"